Repeated Measure Analysis of Dermatitis Symptoms Evolution and Patient-Reported Outcome in N06C4: A Phase 3 Randomized Trial of Mometasone Furoate in Breast Cancer Patients Receiving Radiation Therapy

2013 ◽  
Vol 87 (2) ◽  
pp. S116-S117
Author(s):  
T.T. Sio ◽  
D.J. Schwartz ◽  
P.J. Atherton ◽  
M.A. Neben Wittich ◽  
P.C. Griffin ◽  
...  
2018 ◽  
Vol 44 (7) ◽  
pp. 963-968 ◽  
Author(s):  
M. Lagendijk ◽  
L.S.E. van Egdom ◽  
C. Richel ◽  
N. van Leeuwen ◽  
C. Verhoef ◽  
...  

2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 103s-103s
Author(s):  
Z.Y. Lim ◽  
N. Rajaram ◽  
C.V. Song ◽  
R. Kaur ◽  
N.A. Mohd Taib ◽  
...  

Background: Patient-reported outcome measures (PROMs) are essential for identifying how patients perceive the outcomes of their cancer treatment, and is the ultimate success of cancer care. Although a growing number of studies have focused on PROMs in high income countries (HICs), outcomes relevant to patients in developing countries are less understood. Furthermore, the lack of standardization in PROMs makes it difficult to interpret these data for research or quality monitoring. Aim: In this study, we compared the results of PROM measures between patients in Malaysia, a middle income country, and those in HICs, using standard PROMs questionnaires. We also explored the differences in perceived importance of patient reported outcomes within the multiracial Malaysian cohort. Methods: Breast cancer patients (n=1063) were recruited in hospitals serving suburban areas of Malaysia. Of these, 969 patients were eligible for analysis. The surveys were conducted through face-to-face interviews (68%) or were self-administered (30%). An outcome was considered important if it was scored between 7-9 on a 9-point Likert scale. We compared PROMs scores between Malaysian patients and data previously collected from patients in HICs using logistic regression models, adjusting for demographic and clinical characteristics. A two-step cluster analysis was conducted to explore differences in the perceived importance of PROMs between clusters of Malaysian patients. Results: Compared with 1777 patients from HICs, Malaysian patients were less likely to rate overall and recurrence free survival, as well as emotional, cognitive, social and sexual functioning as very important outcomes. Interestingly, more Malaysian women reported that pain (50% vs. 39%), breast symptoms (51% vs. 35%), and major complications (60% vs. 44%) were very important outcomes ( P < 0.001). Compared with young, married Malaysian women, the cluster of older married women (mean age of 57 vs. 52), who were less likely to have received breast reconstructive surgery (8.6% vs. 16.8%), was more likely to rate sexual functioning (32.8% vs. 25.0%, P = 0.036), body image (63.9% vs. 42.4%, P < 0.001), and satisfaction with the breast (50.7% vs. 37.0%, P = 0.011) as very important outcomes. Conclusion: The differences in breast cancer patient needs between and within populations should be considered carefully to better clinician-patient relationship, patient care and satisfaction and assess the outcomes of our cancer care. Future research is needed to find suitable targeted interventions to identify and address the diverse needs of breast cancer patients in low and middle income countries.


The Breast ◽  
2019 ◽  
Vol 47 ◽  
pp. 10-15
Author(s):  
Bo Angela Wan ◽  
William Pidduck ◽  
Liying Zhang ◽  
Amy Nolen ◽  
Leah Drost ◽  
...  

2021 ◽  
Author(s):  
Andreas Trojan

UNSTRUCTURED Aims: Digital monitoring of treatment related symptoms and patient self-reported outcome gain importance for quality of care in cancer. Here we compare the utility of two versions of a subsequently employed mobile application (app) for monitoring of electronically captured patient-reported outcome (ePRO), and test our hypothesis that an intended shared review of symptoms in patient-physician collaboration creates an impact on the number of data entries. Materials and methods: The Consilium Care app engages cancer patients for standardized reporting of wellbeing and treatment related symptoms in outpatient settings. For descriptive comparison of utility of two slightly different app versions information was made available from an early breast cancer trial (app version 1) and an ongoing study also including patients with advanced disease (version 2). In both app versions, patients and doctors were allowed to share the information from data entries during consultations. App version 2, however, randomly selected symptoms with request for a detailed and shared regular patient-doctor review in order to focus on collection and appropriate interpretation regarding awareness and guidance for severity grading. Number and type of symptom entries, satisfaction with both app versions and patients` perceived effects during consultations were included for the analysis. Results: Symptom severity grading according to CTCAE was performed using a horizontal slider and indicated in descriptive terminology in both apps, while a graphical display facilitated the illustration of symptom history charts. In total, 192 patients electronically reported 11`437 data entries on wellbeing and 33`380 data entries on individual symptoms. 628 (of 872 intended) requested patient-doctor symptom reviews were performed in App version 2. Both, the amount of data entries per patient and day for wellbeing (0.3 vs 1.0; p<0.001) and for symptoms appeared significantly higher in App version 2 (1.3 vs 1.9 data entries; p=0.04).Overall satisfaction with both app versions was high, although version 2 was perceived in general to be more helpful. Conclusions: Request of collaborative patient-doctor symptom review is likely to affect the number of digital symptom data entries.


2019 ◽  
Vol 179 (2) ◽  
pp. 479-489
Author(s):  
M. C. T. Batenburg ◽  
◽  
M. L. Gregorowitsch ◽  
W. Maarse ◽  
A. Witkamp ◽  
...  

Abstract Purpose To evaluate patient-reported cosmetic satisfaction in women treated with radiation therapy for breast cancer and to determine the association between dissatisfaction and quality of life (QoL) and depression. Methods Within the prospective UMBRELLA breast cancer cohort, all patients ≥ 1 year after breast conserving treatment or mastectomy with immediate reconstruction were selected. Self-reported cosmetic satisfaction was measured on a 5-point Likert scale. QoL, social functioning, and emotional functioning were measured using EORTC QLQ-C30 and BR23 at 1, 2, and 3 years after inclusion. Mixed model analysis was performed to assess the difference in different domains of QoL between patients with good versus poor self-reported cosmetic satisfaction over time after adjustment for potential confounders. Depression scores were collected by means of the HADS-NL questionnaire. Chi-square test or Fisher's exact test was used to assess the difference in proportions of HADS score ≥ 8, indicating increased depression risk, between satisfied and dissatisfied patients. Results 808 patients were selected for analysis. Respectively one, two, and three years after surgery, 8% (63/808), 7% (45/626), and 8% (31/409) of patients were dissatisfied with their cosmetic outcome. Poor patient-reported cosmetic satisfaction was independently associated with impaired QoL, body image, and lower emotional and social functioning. Scores ≥ 8 on the HADS depression subscale were significantly more common in dissatisfied patients. Conclusions Dissatisfaction with cosmetic outcome was low after breast cancer surgery followed by radiation therapy during 3 years follow-up. Knowing the association between dissatisfaction with cosmetic outcome and QoL and depression could help to improve the preoperative counseling of breast cancer patients.


Sign in / Sign up

Export Citation Format

Share Document